Skip to main content

The Translational Advisory Board (TAB) is made up of experts in regenerative medicine and clinical practice, entrepreneurs, industrial scientists, investors, and leading subject-matter experts in translation and commercialization. The TAB members serve as co-mentors to the trainees and participate in a monthly seminar series with the trainees, providing trainees continuous contact with these experts.

These TAB advisors enrich the training environment with translational and entrepreneurial skills that are not commonly found among leading academic scientists. TAB advisors provide active and engaged guidance in career survival skills, strategies for finding rewarding job opportunities, clinical needs, entrepreneurial activities, and the translation and commercialization pathway.



  • Dr. Richard Clark, Professor & Vice Chair for Research, Dermatology – Stony Brook
  • Dr. Charles Gatt, Chair & Program Director, Dept. of Orthopedic Surgery – Rutgers
  • Dr. Leonard Lee, Professor and Chief of Cardiothoracic Surgery, Robert Wood Johnson Medical School – Rutgers
  • Dr. Richard Marfuggi, Plastic and Reconstructive Surgeon – Private Practice
  • Dr. Joseph Rosen, Professor of Surgery – Dartmouth-Hitchcock Medical Center
  • Dr. Peter Rubin, Professor and Chair of Plastic Surgery – University of Pittsburgh
  • Dr. Anthony Windebank, Professor of Neurology – Mayo Clinic
  • Dr. Wise Young, Founding Director, W.M. Keck Center for Collaborative Neuroscience – Rutgers


  • Dr. Ted Baker, Professor of Management & Global Business – Rutgers University Business School, Newark and New Brunswick
  • Dr. Scott Wadsworth, Director, US Program Management – Envigo
  • Jennifer Walsh, MBA, Engineering Operations Manager – Medtronic


  • Dr. Nathaniel Bachrach, VP Research & Technology – LifeCell
  • Dr. John Kemnitzer, Senior Director R&D – Integra
  • Dr. Darin Messina, Sr. Director of Research – Allergan
  • Dr. Satish Pulapura, Distinguished Scientist & Technical Fellow – Medtronic
  • Dr. Chand Sishta, Director Regulatory Affairs – Bristol-Myers Squibb